Multiobjective strategies for New Product Development in the pharmaceutical industry

New Product Development (NPD) constitutes a challenging problem in the pharmaceutical industry, due to the characteristics of the development pipeline. Formally, the NPD problem can be stated as follows: select a set of R&D projects from a pool of candidate projects in order to satisfy several criteria (economic profitability, time to market) while coping with the uncertain nature of the projects. More precisely, the recurrent key issues are to determine the projects to develop once target molecules have been identified, their order and the level of resources to assign. In this context, the proposed approach combines discrete event stochastic simulation (Monte Carlo approach) with multiobjective genetic algorithms (NSGAII type, Non-Sorted Genetic Algorithm II) to optimize the highly combinatorial portfolio management problem. In that context, Genetic Algorithms (GAs) are particularly attractive for treating this kind of problem, due to their ability to directly lead to the so-called Pareto front and to account for the combinatorial aspect. This work is illustrated with a study case involving nine interdependent new product candidates targeting three diseases. An analysis is performed for this test bench on the different pairs of criteria both for the bi- and tricriteria optimization: large portfolios cause resource queues and delays time to launch and are eliminated by the bi- and tricriteria optimization strategy. The optimization strategy is thus interesting to detect the sequence candidates. Time is an important criterion to consider simultaneously with NPV and risk criteria. The order in which drugs are released in the pipeline is of great importance as with scheduling problems

Multiobjective strategies for New Product Development in the pharmaceutical industry

New Product Development (NPD) constitutes a challenging problem in the pharmaceutical industry, due to the characteristics of the development pipeline. Formally, the NPD problem can be stated as follows: select a set of R&D projects from a pool of candidate projects in order to satisfy several criteria (economic profitability, time to market) while coping with the uncertain nature of the projects. More precisely, the recurrent key issues are to determine the projects to develop once target molecules have been identified, their order and the level of resources to assign. In this context, the proposed approach combines discrete event stochastic simulation (Monte Carlo approach) with multiobjective genetic algorithms (NSGAII type, Non-Sorted Genetic Algorithm II) to optimize the highly combinatorial portfolio management problem. In that context, Genetic Algorithms (GAs) are particularly attractive for treating this kind of problem, due to their ability to directly lead to the so-called Pareto front and to account for the combinatorial aspect. This work is illustrated with a study case involving nine interdependent new product candidates targeting three diseases. An analysis is performed for this test bench on the different pairs of criteria both for the bi- and tricriteria optimization: large portfolios cause resource queues and delays time to launch and are eliminated by the bi- and tricriteria optimization strategy. The optimization strategy is thus interesting to detect the sequence candidates. Time is an important criterion to consider simultaneously with NPV and risk criteria. The order in which drugs are released in the pipeline is of great importance as with scheduling problems

Synchronization and state estimation for discrete-time complex networks with distributed delays

Copyright [2008] IEEE. This material is posted here with permission of the IEEE. Such permission of the IEEE does not in any way imply IEEE endorsement of any of Brunel University's products or services. Internal or personal use of this material is permitted. However, permission to reprint/republish this material for advertising or promotional purposes or for creating new collective works for resale or redistribution must be obtained from the IEEE by writing to [email protected]. By choosing to view this document, you agree to all provisions of the copyright laws protecting it.In this paper, a synchronization problem is investigated for an array of coupled complex discrete-time networks with the simultaneous presence of both the discrete and distributed time delays. The complex networks addressed which include neural and social networks as special cases are quite general. Rather than the commonly used Lipschitz-type function, a more general sector-like nonlinear function is employed to describe the nonlinearities existing in the network. The distributed infinite time delays in the discrete-time domain are first defined. By utilizing a novel Lyapunov-Krasovskii functional and the Kronecker product, it is shown that the addressed discrete-time complex network with distributed delays is synchronized if certain linear matrix inequalities (LMIs) are feasible. The state estimation problem is then studied for the same complex network, where the purpose is to design a state estimator to estimate the network states through available output measurements such that, for all admissible discrete and distributed delays, the dynamics of the estimation error is guaranteed to be globally asymptotically stable. Again, an LMI approach is developed for the state estimation problem. Two simulation examples are provided to show the usefulness of the proposed global synchronization and state estimation conditions. It is worth pointing out that our main results are valid even if the nominal subsystems within the network are unstable

Reverse engineering of logic-based differential equation models using a mixed-integer dynamic optimization approach

9 páginas, 6 figuras.-- This is an Open Access article distributed under the terms of the Creative Commons Attribution LicenseMotivation: Systems biology models can be used to test new hypotheses formulated on the basis of previous knowledge or new experimental data, contradictory with a previously existing model. New hypotheses often come in the shape of a set of possible regulatory mechanisms. This search is usually not limited to finding a single regulation link, but rather a combination of links subject to great uncertainty or no information about the kinetic parameters. Results: In this work, we combine a logic-based formalism, to describe all the possible regulatory structures for a given dynamic model of a pathway, with mixed-integer dynamic optimization (MIDO). This framework aims to simultaneously identify the regulatory structure (represented by binary parameters) and the real-valued parameters that are consistent with the available experimental data, resulting in a logic-based differential equation model. The alternative to this would be to perform real-valued parameter estimation for each possible model structure, which is not tractable for models of the size presented in this work. The performance of the method presented here is illustrated with several case studies: a synthetic pathway problem of signaling regulation, a two-component signal transduction pathway in bacterial homeostasis, and a signaling network in liver cancer cellsD.H., J.R.B. and J.S.R. acknowledge funding from the EU FP7 projects ‘NICHE’ (ITN Grant number 289384) and ‘BioPreDyn’ (KBBE grant number 289434). J.R.B. also acknowledges funding from the Spanish Ministerio de Economía y Competitividad (and the FEDER) through the project MultiScales (DPI2011-28112-C04-03).Peer reviewe

Variable-fidelity electromagnetic simulations and co-kriging for accurate modeling of antennas

Accurate and fast models are indispensable in contemporary antenna design. In this paper, we describe the low-cost antenna modeling methodology involving variable-fidelity electromagnetic (EM) simulations and co-Kriging. Our approach exploits sparsely sampled accurate (high-fidelity) EM data as well as densely sampled coarse-discretization (low-fidelity) EM simulations that are accommodated into one model using the co-Kriging technique. By using coarse-discretization simulations, the computational cost of creating the antenna model is greatly reduced compared to conventional approaches, where high-fidelity simulations are directly used to set up the model. At the same time, the modeling accuracy is not compromised. The proposed technique is demonstrated using three examples of antenna structures. Comparisons with conventional modeling based on high-fidelity data approximation, as well as applications for antenna design, are also discussed

Reverse engineering of logic-based differential equation models using a mixed-integer dynamic optimisation approach

Motivation: Systems biology models can be used to test new hypotheses formulated on the basis of previous knowledge or new experimental data, contradictory with a previously existing model. New hypotheses often come in the shape of a set of possible regulatory mechanisms. This search is usually not limited to finding a single regulation link, but rather a combination of links subject to great uncertainty or no information about the kinetic parameters.Results: In this work, we combine a logic-based formalism, to describe all the possible regulatory structures for a given dynamic model of a pathway, with mixed-integer dynamic optimization (MIDO). This framework aims to simultaneously identify the regulatory structure (represented by binary parameters) and the real-valued parameters that are consistent with the available experimental data, resulting in a logic-based differential equation model. The alternative to this would be to perform real-valued parameter estimation for each possible model structure, which is not tractable for models of the size presented in this work. The performance of the method presented here is illustrated with several case studies: a synthetic pathway problem of signaling regulation, a two component signal transduction pathway in bacterial homeostasis, and a signaling network in liver cancer cells.D.H., J.R.B. and J.S.R. acknowledge funding from the EU FP7 projects 'NICHE' (ITN Grant number 289384) and 'BioPreDyn' (KBBE grant number 289434). J.R.B. also acknowledges funding from the Spanish Ministerio de Economia y Competitividad (and the FEDER) through the project MultiScales (DPI2011-28112-C04-03)